Guide for Aviation Medical Examiners
Decision Considerations - Aerospace Medical Dispositions
Item 40. Skin
Disease/Condition | Evaluation Data | Disposition |
---|---|---|
Unknown pathology | If unable to verify pathology, have airman collect:
☐ Medical records describing the diagnosis and treatment; and ☐ Pathology report(s) |
More information needed Once reports are received, refer to the appropriate skin cancer diagnosis in this section. |
Basal cell cancer (BCC)
Squamous cell cancer(SCC) Uncomplicated skin only. No organ involvement |
AME interview and exam findings consistent with uncomplicated local BCC or SCC completely treated (excised, destroyed, or Mohs procedure) and resolved. | ISSUE Note BCC or SCC treated in block 60. If complicated lesion, see below. |
SCC or BCC
Complicated lesion Metastatic lymph node or deep tissue involvement, aggressive pathology or other abnormalities Also see ENT section |
Submit the following for FAA review:
☐ Medical records describing the diagnosis and treatment; ☐ Pathology report(s); ☐ Operative notes; ☐ Current status summary report that includes current or planned future treatment & prognosis; and ☐ Copies of any imaging performed (CT/MRI) |
DEFER Submit reports to FAA for review. Follow-up certification - based on Special Issuance Authorization. |
Melanoma
Less than 0.75 mm in depth OR Melanoma in Situ |
Review:
☐ Medical records describing the diagnosis and treatment; and ☐ Pathology report(s); |
ISSUE If complete resection with clear margins, no recurrence, no metastatic disease, and favorable reports. Document in block 60 AND submit reports to FAA for retention in the file. |
Melanoma
Equal to 0.75 mm or greater in depth |
Review and submit the following:
☐ Medical records describing the diagnosis and treatment; ☐ Pathology report(s); ☐ Operative notes; ☐ Current status report that includes if any additional lesions, any metastatic disease, any current or future treatment planned; and ☐ Current MRI brain |
DEFER Submit reports to FAA for review. Follow-up certification - based on Special Issuance Authorization. |
Metastatic Melanoma
OR Melanoma of Unknown Primary Origin |
Submit the following for FAA review:
☐ Info from Melanoma greater than 0.75 mm above; ☐ PET scan; and ☐ Copies of any additional testing performed by your treating physician not listed above |
DEFER Submit supporting documents for FAA review. |